Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Science (008930 KS)
Watchlist
70
Analysis
Health Care
•
South Korea
Hanmi Science Co., Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
13 Dec 2023 07:00
KRX Short Interest Weekly (Dec 8th): Naver
We analyzed the KRX short interest report for the past week and we highlighted weekly KRX short interest changes in Naver.
Ke Yan, CFA, FRM
Follow
553 Views
Share
bearish
•
Ecopro Co Ltd
•
02 Oct 2023 21:33
Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2023
In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 4Q 2023. We highlight 38 pair trades that...
Douglas Kim
Follow
767 Views
Share
bullish
•
SK Biopharmaceuticals
•
11 Sep 2023 03:39
KRX New Deal Index Rebalance Preview: Review Period Nearly Complete
The changes to the index were announced post market close on Friday and will be implemented at the close on Thursday. Given that the changes are...
Brian Freitas
Follow
1.2k Views
Share
bearish
•
MOG Digitech
•
30 Jul 2023 05:48
Index Rebalance & ETF Flow Recap: LQ45/IDX30, FXI, New Deal, KOSPI, KQ150, LG Energy, IN Float, TTMT
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
698 Views
Share
bullish
•
Samsung C&T
•
15 Jul 2023 03:35
Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2023
In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 3Q 2023. We highlight 38 pair trades that...
Douglas Kim
Follow
760 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x